Demirci et al identified prognostic factors predicting visual acuity after chemoreduction in a patient with retinoblastoma. The authors are from Wills Eye Hospital (Thomas Jefferson University) and the Children's Hospital of Philadelphia.
Chemoreduction was done using a combination of carboplatin, etoposide phosphate and vincristine sulfate.
Prognostic factors for visual acuity 20/40 or better:
(1) tumor margin from optic disc >= 3 mm (100% if >= 3 mm, 34% if < 3 mm)
(2) tumor margin from foveola >= 3 mm (relative risk 14.5)
(3) subretinal fluid absent at initial examination (relative risk 14.5)
Distance from Foveola |
Subretinal Fluid |
Distance from Optic Disc |
Chances of Visual Acuity 20/40+ |
>= 3 mm |
absent |
>= 3 mm |
good |
>= 3 mm |
absent |
< 3 mm |
fair |
>= 3 mm |
present |
>= 3 mm |
guarded |
>= 3 mm |
present |
< 3 mm |
poor |
< 3 mm |
absent |
>= 3 mm |
guarded |
< 3 mm |
absent |
< 3 mm |
poor |
< 3 mm |
present |
>= 3 mm |
poor |
< 3 mm |
present |
< 3 mm |
very poor |
where:
• The foveola ("small pit") is located within the macula.
Prognostic factors for visual acuity of 20/200 or better:
(1) tumor margin from foveola >= 3 mm (100% if >= 3 mm, 44% if < 3 mm)
(2) tumor thickness < 6 mm (relative risk 7)
Tumor Thickness |
Distance from Foveola |
Chances of Visual Acuity at least 20/200 |
< 6 mm |
>= 3 mm |
good |
< 6 mm |
< 3 mm |
fair |
>= 6 mm |
>= 3 mm |
guarded |
>= 6 mm |
< 3 mm |
poor |
Specialty: Hematology Oncology, Ophthalmology